The Glioma Longitudinal AnalySiS (GLASS) consortium comprising neuropathologists, clinicians, scientists, and bioinformaticians from leading institutions across the globe was inaugurated in 2015, to accelerate efforts to (1) understand glioma tumor evolution and (2) expose therapeutic vulnerabilities.
GLASS aims to achieve these goals through molecular profiling of tumor specimens obtained at multiple time points along the course of glioma disease, in the context of precise clinical annotation and imaging. Towards that purpose, GLASS has curated a molecular Data Resource that is publicly accessible. The current Data Resource includes multi-timepoint molecular profiles from more than 200 patients with a glioma.
Read our position paper: The Glioma Longitudinal Analysis Consortium. Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro Oncol. 2018 PMID: 29432615.
Please use the menu (in the upper right corner) to navigate through our webpages and learn more.